Evidence map›Paper›PMID 22530012›Full record

ArticlePloS one2012

Conformational states of a bacterial α2-macroglobulin resemble those of human complement C3.

David Neves, Leandro F Estrozi, Viviana Job, Frank Gabel, Guy Schoehn, Andréa Dessen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Plasma proteome changes in cord blood samples from preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2018
    Article
  4. Article
  5. Article
  6. Article
  7. Structural and functional insights into Escherichia coli α2-macroglobulin endopeptidase snap-trap inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  8. Article
  9. Neutrophil serine proteases in antibacterial defense.Current opinion in microbiology · 2015
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

David NevesInstitut de Biologie Structurale, Université Grenoble I, Grenoble, France. andrea.dessen@ibs.fr
Leandro F Estrozi
Viviana Job
Frank Gabel
Guy Schoehn
Andréa Dessen
Université Grenoble Alpes · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCEA Grenoble · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α(2) macroglobulins (α(2)Ms) are broad-spectrum protease inhibitors that play essential roles in the innate immune system of eukaryotic species. These large, multi-domain proteins are characterized by a broad-spectrum bait region and an internal thioester, which, upon cleavage, becomes covalently associated to the target protease, allowing its entrapment by a large conformational modification. Notably, α(2)Ms are part of a larger protein superfamily that includes proteins of the complement system, such as C3, a multi-domain macromolecule which is also characterized by an internal thioester-carrying domain and whose activation represents the pivotal step in the complement cascade. Recently, α(2)M/C3-like genes were identified in a large number of bacterial genomes, and the Escherichia coli α(2)M homolog (ECAM) was shown to be activated by proteases. In this work, we have structurally characterized ECAM by electron microscopy and small angle scattering (SAXS) techniques. ECAM is an elongated, flexible molecule with overall similarities to C3 in its inactive form; activation by methylamine, chymotrypsin, or elastase induces a conformational modification reminiscent of the one undergone by the transformation of C3 into its active form, C3b. In addition, the proposed C-terminus of ECAM displays high flexibility and different conformations, and could be the recognition site for partner macromolecules. This work sheds light on a potential bacterial defense mechanism that mimics structural rearrangements essential for activation of the complement cascade in eukaryotes, and represents a possible novel target for the development of antibacterials.

Indexed as

alpha-MacroglobulinsBacterial ProteinsComplement C3Complement C3bHumansModels, MolecularProtein Conformationalpha-MacroglobulinsBacterial ProteinsComplement C3Complement C3b

Identifiers

PMID22530012
PMCPMC3328433
OpenAlexW2021590473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.